Sushma Bartaula-Brevik

Author

University of Bergen ORCID

Also Known As

Sushma Bartaula-Brevik

Publications

323

Citations

H-Index

Concepts

All Affiliations

University of Bergen Haukeland University Hospital

About

Sushma Bartaula-Brevik is an author at University of Bergen specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	166
2	Cell Biology	6	6	166
3	Health Sciences	4	4	126
4	Engineering	1	1	21
5	Biomedical Engineering	1	1	21

Sushma Bartaula-Brevik

Publications

207

Citations

H-Index

Page 1

	Year	Citations
Proteome and Phosphoproteome Changes Associated with Prognosis in Acute Myeloid Leukemia Elise Aasebø, Frode S. Berven, Sushma Bartaula-Brevik, Cancers Mixed-phenotype Acute LeukemiaKinase InhibitorsPathologyCell DeathTumor Biology	2020	47
Targeting Cellular Metabolism in Acute Myeloid Leukemia and the Role of Patient Heterogeneity Ida Sofie Grønningsæter, Håkon Reikvam, Elise Aasebø, Cells Chemoprevention StrategyMixed-phenotype Acute LeukemiaTumor BiologyMyeloid NeoplasiaHematological Malignancy	2020	38
Secretome of Mesenchymal Stem Cells Grown in Hypoxia Accelerates Wound Healing and Vessel Formation In Vitro Sushma Bartaula-Brevik International Journal of Stem cell Research & Therapy Vessel FormationAdult Stem CellImmunologySkin RegenerationRegenerative Medicine	2017	24
High Constitutive Cytokine Release by Primary Human Acute Myeloid Leukemia Cells Is Associated with a Specific Intercellular Communication Phenotype Håkon Reikvam, Elise Aasebø, Annette K. Brenner, Journal of Clinical Medicine	2019	24
Angiogenic and Immunomodulatory Properties of Endothelial and Mesenchymal Stem Cells Sushma Bartaula-Brevik, Torbjørn Ø. Pedersen, Anna Finne‐Wistrand, Tissue Engineering Part A Tissue EngineeringEngineeringAdult Stem CellImmunologyBiomedical Engineering	2015	21
Effects of the Autophagy-Inhibiting Agent Chloroquine on Acute Myeloid Leukemia Cells; Characterization of Patient Heterogeneity Ida Sofie Grønningsæter, Håkon Reikvam, Elise Aasebø, Journal of Personalized Medicine Mixed-phenotype Acute LeukemiaImmunologyCell DeathMyeloid NeoplasiaHematological Malignancy	2021	19
Two acute myeloid leukemia patient subsets are identified based on the constitutive PI3K-Akt-mTOR signaling of their leukemic cells; a functional, proteomic, and transcriptomic comparison Ina Nepstad, Kimberley Joanne Hatfield, Elise Aasebø, Expert Opinion on Therapeutic Targets	2018	17
The Capacity of Long-Term In Vitro Proliferation of Acute Myeloid Leukemia Cells Supported Only by Exogenous Cytokines Is Associated with a Patient Subset with Adverse Outcome Annette K. Brenner, Elise Aasebø, Maria Hernandez-Valladares, Cancers Mixed-phenotype Acute LeukemiaImmunologyCell ProliferationMyeloid NeoplasiaHematological Malignancy	2019	17

Page 1